Tourmaline Bio (TRML) Misses Q2 EPS by 68c
Tweet
Share
E-mailGet Alerts TRML Hot Sheet
Join SI Premium – FREE
Tourmaline Bio (NASDAQ: TRML) reported Q2 EPS of ($0.68).
For earnings history and earnings-related data on Tourmaline Bio (TRML) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump: Iran Will Pay For US Forces Killings Many Times Over
- Travelers (TRV) PT Raised to $340 at Freedom Broker
- Jefferies Reiterates Buy Rating on NewAmsterdam Pharma Co NV (NAMS)
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
